Finance

Beta
Lists
DOC:NYSE
Healthpeak Properties, Inc
$19.07
-1.95%
(-0.38) 1D
$19.07
0.00% (0.00)
After hours
Closed: Jun 3, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DOC...
Open
$19.31
High
$19.49
Low
$19.07
Mkt. cap
13.15B
Avg. vol.
10.47M
Volume
6.12M
Dividend
6.40%
Quarterly dividend
$0.31
Ex-dividend date
Jun 15, 2026
P/E ratio
59.82
52-wk high
$20.27
52-wk low
$15.70
EPS
$0.32
Beta
1.07
Shares outstanding
689.42M
No. of employees
411
Open
$19.31
High
$19.49
Low
$19.07
Mkt. cap
13.15B
Avg. vol.
10.47M
Volume
6.12M
Dividend
6.40%
Quarterly dividend
$0.31
Ex-dividend date
Jun 15, 2026
P/E ratio
59.82
52-wk high
$20.27
52-wk low
$15.70
EPS
$0.32
Beta
1.07
Shares outstanding
689.42M
No. of employees
411
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to DOC in the past 3 months
Buy
Buy
6
Hold
5
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for DOC in the last 3 months.
Highest
Current $19.07
$21.00 (+10.12%)
Average
$20.09 (+5.35%)
Lowest
$17.00 (-10.85%)
News stories
From sources across the web
Profile
Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties. Wikipedia
About Healthpeak Properties, Inc
CEOScott M. Brinker
Employees411
FoundedMar 1985
HeadquartersDenver, Colorado, United States
SectorReal estate investment trust
Websitehcpi.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.28 / $0.06
+366.67%beat
Revenue / Est. (USD)
752.95M / 693.13M
+8.63%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
694.35M
705.87M
719.40M
752.95M
Cost of goods sold
283.40M
292.34M
279.33M
345.96M
Cost of revenue
283.40M
292.34M
279.33M
345.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.76M
19.91M
33.63M
24.59M
Operating expense
286.68M
282.22M
295.71M
314.32M
Total operating expenses
570.08M
574.57M
575.04M
660.28M
Operating income
124.27M
131.31M
144.36M
92.67M
Other non operating income
-4.69M
1.16M
11.14M
1.47M
EBT including unusual items
41.40M
-111.05M
127.82M
199.91M
EBT excluding unusual items
46.26M
-120.61M
77.57M
11.12M
Income tax expense
2.38M
-1.21M
6.03M
254.00K
Effective tax rate
5.75%
1.09%
4.72%
0.13%
Other operating expenses
-
-
-
-
Net income
31.67M
-117.12M
113.97M
193.63M
Net profit margin
4.56%
-16.59%
15.84%
25.72%
Earnings per share
0.06
-0.18
0.10
-
Interest and investment income
-
-
-
-
Interest expense
-75.06M
-76.78M
-80.64M
-87.29M
Net interest expenses
-75.06M
-76.78M
-80.64M
-87.29M
Depreciation and amortization charges
265.92M
262.32M
262.09M
289.73M
EBITDA
390.19M
393.62M
369.95M
375.81M
Gain or loss from assets sale
-1.64M
-11.50M
-56.35M
-50.67M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer